These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3148481)

  • 41. Haemolytic disease of the newborn: the new NICE guidelines.
    Thompson J
    J Fam Health Care; 2002; 12(5):133-6. PubMed ID: 12449064
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Management of severe red cell immunization in pregnancy.
    Kanhai HH
    Eur J Obstet Gynecol Reprod Biol; 1991 Dec; 42 Suppl():S90-5. PubMed ID: 1809617
    [No Abstract]   [Full Text] [Related]  

  • 43. [Perinatal hemolytic disease caused by Rh incompatibility as a true social scourge. Interview between "Minerva Medica" and Professor Franco Gasparri].
    Barraciu A
    Minerva Med; 1970 Dec; 61(102 Suppl):5-8. PubMed ID: 5497702
    [No Abstract]   [Full Text] [Related]  

  • 44. Obstetric management of Rh immunization including intrauterine transfusion and immunotherapy.
    Scott JR
    Mead Johnson Symp Perinat Dev Med; 1982; (19):33-8. PubMed ID: 6821467
    [No Abstract]   [Full Text] [Related]  

  • 45. [On the prevention of Rh immunization in Sweden].
    Bartsch FK; Bergman PO; Bååthe P; Dahlen-Nilsson I; Hansson LA; Ryttinger LA
    Bibl Haematol; 1969; 32():135-40. PubMed ID: 4980799
    [No Abstract]   [Full Text] [Related]  

  • 46. Haemolytic disease of the newborn caused by rhesus isoimmunization (anti-c).
    Felc Z
    East Mediterr Health J; 2001 Nov; 7(6):1065-9. PubMed ID: 15332750
    [No Abstract]   [Full Text] [Related]  

  • 47. Prevention of Rh isoimmunization.
    Clarke CA
    Prog Med Genet; 1972; 8():169-223. PubMed ID: 4110995
    [No Abstract]   [Full Text] [Related]  

  • 48. [Treatment of the fetus with Rh incompatibility by the combined methods of plasmapheresis and intrauterine blood transfusion].
    Lozińska D; Radomska I; Samborska K; Dmoch E; Garwoliński J; Lenkiewicz B; Góralski T
    Pol Tyg Lek; 1988 Nov; 43(45):1449-51. PubMed ID: 3151013
    [No Abstract]   [Full Text] [Related]  

  • 49. [Results of the use of plasmapheresis in the treatment of Rh incompatibility].
    Czeszyńska M; Cretti A; Rzechuła H; Malinowska-Szutowicz Z
    Acta Haematol Pol; 1988; 19(1-2):47-55. PubMed ID: 3149110
    [No Abstract]   [Full Text] [Related]  

  • 50. [Two cases of unusual allo-immunization caused by atypical antibodies].
    Le Vaillant C; Jacopin-Bruneau L; Nowak C; Riteau AS
    Presse Med; 2015 Oct; 44(10):1078-82. PubMed ID: 26319768
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effect of obstetrical procedures on the incidence and intensity of Rh incompatibility].
    Poreba R; Pozowski J; Pudełko L
    Acta Haematol Pol; 1988; 19(1-2):27-32. PubMed ID: 3149108
    [No Abstract]   [Full Text] [Related]  

  • 52. [Isoimmunization to Kell factor, during pregnancy].
    Krug A; Bianchi R; Cornejo A; Farias S; Fuentes L
    Rev Chil Obstet Ginecol; 1988; 53(4):198-200. PubMed ID: 3155245
    [No Abstract]   [Full Text] [Related]  

  • 53. Reported management of threatened miscarriage by general practitioners in Wessex.
    Collinge JD
    Br Med J (Clin Res Ed); 1987 Nov; 295(6610):1415. PubMed ID: 3121037
    [No Abstract]   [Full Text] [Related]  

  • 54. [Hemosorption in the prevention of severe forms of hemolytic disease of the newborn in rhesus sensitization].
    Konopliannikov AG; Saĭkina EA; Goriushina NB; Panina OB
    Akush Ginekol (Mosk); 1993; (6):31-3. PubMed ID: 8311153
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Evaluation of the Center for Rh-negative Mothers. Hospital Paula Jaraquemada (3 years)].
    Krug A; Bianchi R; Pérez N; Ilabaca G; Farías S; Rojas E
    Rev Chil Obstet Ginecol; 1981; 46(4):206-14. PubMed ID: 6099901
    [No Abstract]   [Full Text] [Related]  

  • 56. Noninvasive fetal Rh genotyping: the time has come.
    Queenan JT
    Obstet Gynecol; 2005 Oct; 106(4):682-3. PubMed ID: 16199621
    [No Abstract]   [Full Text] [Related]  

  • 57. The effectiveness of intrauterine transfusions.
    Lozińska D; Radomska I; Niedzicka E; Dmoch E; Czerwoniec W
    Arch Immunol Ther Exp (Warsz); 1987; 35(6):769-73. PubMed ID: 3149460
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rhesus disease: the model for fetal therapy.
    Nicolaides KH; Rodeck CH
    Br J Hosp Med; 1985 Sep; 34(3):141-8. PubMed ID: 3933599
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Prenatal diagnosis and prevention of hemolytic disease of newborn].
    Fischer K
    Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():64-9. PubMed ID: 8374293
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Rh alloimmunization].
    Boda D; Pataki L
    Orv Hetil; 1996 Nov; 137(44):2485. PubMed ID: 9026764
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.